FIRST-PERSON: Science benefits from ethical standards
Stable human embryonic stem cell lines, or hESCs, were first reported and described for scientific research in 1998. To some, these cells promised an ideal source of testing material for new drugs and therapies because they could be grown in the lab indefinitely without losing their characteristics and turn into any cell in the body.
